Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance
26 Apr 2016
Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance
Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy
WIN 2016: Preview of themes
WIN 2016: Preview of Speakers
EBMT 2016 Highlights: Expert discussion
Novel technologies for understanding the repertoire of tumour infiltrating T cells in cancer
The role of microRNAs in modulation of the immune escape of tumors
Biomarkers in t-cell therapy trials
Immunotherapy and personalised medicine in review
Targeting tumour vasculature by DNA vaccines
The UICC TNM Classification System: Free e-learning available now
Genome instability can be exploited for cancer therapy